{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:14:44Z","timestamp":1790651684932,"version":"4.1.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.cyto.2020.155256","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T12:22:12Z","timestamp":1597926132000},"page":"155256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis"],"prefix":"10.1016","volume":"136","author":[{"given":"Maryse","family":"Cloutier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuparna","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awais Ullah","family":"Ihsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues Allard","family":"Chamard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7563-576X","authenticated-orcid":false,"given":"Subburaj","family":"Ilangumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheela","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2020.155256_b0005","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cyto.2020.155256_b0010","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(20)30129-8","article-title":"Can we contain the COVID-19 outbreak with the same measures as for SARS?","volume":"20","author":"Wilder-Smith","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.cyto.2020.155256_b0015","article-title":"Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet?","volume":"24","author":"Ceccarelli","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cyto.2020.155256_b0020","doi-asserted-by":"crossref","unstructured":"M. Hoffmann, H. Kleine-Weber, S. Schroeder, N. Kruger, T. Herrler, S. Erichsen, T.S. Schiergens, G. Herrler, N.H. Wu, A. Nitsche, M.A. Muller, C. Drosten, S. Pohlmann, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell 181(2) (2020) 271-280 e8 10.1016\/j.cell.2020.02.052.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"10.1016\/j.cyto.2020.155256_b0025","doi-asserted-by":"crossref","unstructured":"S. Lukassen, R.L. Chua, T. Trefzer, N.C. Kahn, M.A. Schneider, T. Muley, H. Winter, M. Meister, C. Veith, A.W. Boots, B.P. Hennig, M. Kreuter, C. Conrad, R. Eils, SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells, EMBO J 39(10) (2020) e105114 10.15252\/embj.20105114.","DOI":"10.15252\/embj.20105114"},{"key":"10.1016\/j.cyto.2020.155256_b0030","unstructured":"P. Pavone, M. Ceccarelli, R. Taibi, G. La Rocca, G. Nunnari, Outbreak of COVID-19 infection in children: fear and serenity, Eur Rev Med Pharmacol Sci 24(8) (2020) 4572-4575 10.26355\/eurrev_202004_21043."},{"key":"#cr-split#-10.1016\/j.cyto.2020.155256_b0035.1","doi-asserted-by":"crossref","unstructured":"D. Korean Society of Infectious, D. Korean Society of Pediatric Infectious, E. Korean Society of, T. Korean Society for Antimicrobial, C. Korean Society for Healthcare-associated Infection, Prevention, C. Korea Centers for Disease, Prevention, Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020, J Korean Med Sci 35","DOI":"10.3346\/jkms.2020.35.e112"},{"key":"#cr-split#-10.1016\/j.cyto.2020.155256_b0035.2","unstructured":"(10) (2020) e112 10.3346\/jkms.2020.35.e112."},{"issue":"4","key":"10.1016\/j.cyto.2020.155256_b0040","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00607-2020","article-title":"Pathogenesis of COVID-19 from a cell biology perspective","volume":"55","author":"Mason","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cyto.2020.155256_b0045","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.8438","article-title":"Asymptomatic seroconversion of immunoglobulins to SARS-CoV-2 in a pediatric dialysis unit","author":"Hains","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cyto.2020.155256_b0050","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2215\/CJN.03340320","article-title":"Mitigating risk of COVID-19 in dialysis facilities","volume":"15","author":"Kliger","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"18","key":"10.1016\/j.cyto.2020.155256_b0055","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.1128\/JVI.00649-06","article-title":"Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens","volume":"80","author":"Leung","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2020.155256_b0060","first-page":"1","article-title":"How we mitigate and contain COVID-19 outbreak in hemodialysis center (HD): lessons and experiences","author":"Su","year":"2020","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.cyto.2020.155256_b0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cytogfr.2020.05.002","article-title":"COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons","volume":"53","author":"Nile","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2020.155256_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.cyto.2020.155256_b0075","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/ajrccm.163.4.9909121","article-title":"The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia","volume":"163","author":"Ho","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2020.155256_b0080","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa489","article-title":"Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Qu","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cyto.2020.155256_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.012","article-title":"Profile of specific antibodies to SARS-CoV-2: the first report","author":"Xiao","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.cyto.2020.155256_b0090","article-title":"Longitudinal change of SARS-Cov2 antibodies in patients with COVID-19","author":"Zhang","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2020.155256_b0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2020.155256_b0100","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa310","article-title":"Profiling early humoral response to diagnose novel Coronavirus Disease (COVID-19)","author":"Guo","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cyto.2020.155256_b0105","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.cyto.2020.155256_b0110","doi-asserted-by":"crossref","DOI":"10.3201\/eid2607.200841","article-title":"Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients","volume":"26","author":"Okba","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cyto.2020.155256_b0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2020.155256_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.04.023","article-title":"Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals","author":"Ni","year":"2020","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cyto.2020.155256_b0125","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.micinf.2020.02.006","article-title":"Is COVID-19 receiving ADE from other coronaviruses?","volume":"22","author":"Tetro","year":"2020","journal-title":"Microbes Infect."},{"issue":"Pt 9","key":"10.1016\/j.cyto.2020.155256_b0130","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1099\/0022-1317-83-9-2091","article-title":"Occupancy and mechanism in antibody-mediated neutralization of animal viruses","volume":"83","author":"Klasse","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/imr.12367","article-title":"Fc receptors in antibody-dependent enhancement of viral infections","volume":"268","author":"Taylor","year":"2015","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/tra.12012","article-title":"Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans","volume":"14","author":"Flipse","year":"2013","journal-title":"Traffic"},{"issue":"10","key":"10.1016\/j.cyto.2020.155256_b0145","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1473-3099(10)70166-3","article-title":"Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes","volume":"10","author":"Halstead","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0150","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1084\/jem.158.1.258","article-title":"Complement receptor mediates enhanced flavivirus replication in macrophages","volume":"158","author":"Cardosa","year":"1983","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cyto.2020.155256_b0155","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00002030-199405000-00005","article-title":"Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease","volume":"8","author":"Fust","year":"1994","journal-title":"AIDS"},{"issue":"14","key":"10.1016\/j.cyto.2020.155256_b0160","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1128\/JVI.00649-14","article-title":"Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q","volume":"88","author":"von Kietzell","year":"2014","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.cyto.2020.155256_b0165","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ni.2939","article-title":"Type I and type II Fc receptors regulate innate and adaptive immunity","volume":"15","author":"Pincetic","year":"2014","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155256_b0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1074-7613(02)00287-X","article-title":"FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses","volume":"16","author":"Barnes","year":"2002","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cyto.2020.155256_b0175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1074-7613(02)00294-7","article-title":"FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection","volume":"16","author":"Ioan-Facsinay","year":"2002","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.cyto.2020.155256_b0180","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.1003526","article-title":"Functional characteristics of the high affinity IgG receptor, FcgammaRI","volume":"186","author":"van der Poel","year":"2011","journal-title":"J. Immunol."},{"issue":"540","key":"10.1016\/j.cyto.2020.155256_b0185","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaq0891","article-title":"Mechanisms of inside-out signaling of the high-affinity IgG receptor FcgammaRI","volume":"11","author":"Brandsma","year":"2018","journal-title":"Sci. Signal"},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/imr.12482","article-title":"Anti-retroviral antibody FcgammaR-mediated effector functions","volume":"275","author":"Bournazos","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2020.155256_b0195","doi-asserted-by":"crossref","unstructured":"M. Li, L. Zhao, C. Zhang, X. Wang, W. Hong, J. Sun, R. Liu, L. Yu, J. Wang, F. Zhang, X. Jin, Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors, PLoS One 13(7) (2018) e0200478 10.1371\/journal.pone.0200478.","DOI":"10.1371\/journal.pone.0200478"},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0200","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jmv.21051","article-title":"Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells","volume":"80","author":"Kou","year":"2008","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.cyto.2020.155256_b0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.virol.2011.08.026","article-title":"Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement","volume":"421","author":"Sun","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.cyto.2020.155256_b0210","doi-asserted-by":"crossref","first-page":"29201","DOI":"10.1038\/srep29201","article-title":"Antibody-dependent enhancement of dengue virus infection in primary human macrophages; balancing higher fusion against antiviral responses","volume":"6","author":"Flipse","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.cyto.2020.155256_b0215","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2020.155256_b0220","first-page":"67","article-title":"Markers of dengue disease severity","volume":"338","author":"Srikiatkhachorn","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.cyto.2020.155256_b0225","first-page":"301","article-title":"Immune enhancement of viral infection","volume":"31","author":"Halstead","year":"1982","journal-title":"Prog. Allergy"},{"issue":"6365","key":"10.1016\/j.cyto.2020.155256_b0230","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"issue":"7707","key":"10.1016\/j.cyto.2020.155256_b0235","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41586-018-0157-4","article-title":"Reconstruction of antibody dynamics and infection histories to evaluate dengue risk","volume":"557","author":"Salje","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2020.155256_b0240","doi-asserted-by":"crossref","first-page":"16164","DOI":"10.1038\/nmicrobiol.2016.164","article-title":"Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity","volume":"1","author":"Chan","year":"2016","journal-title":"Nat. Microbiol."},{"issue":"7","key":"10.1016\/j.cyto.2020.155256_b0245","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S1473-3099(17)30340-7","article-title":"Zika enhancement: a reality check","volume":"17","author":"Mahalingam","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1473-3099(19)30697-8","article-title":"Viral emergence and immune interplay in flavivirus vaccines","volume":"20","author":"Fischer","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"6427","key":"10.1016\/j.cyto.2020.155256_b0255","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.aav6618","article-title":"Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region","volume":"363","author":"Rodriguez-Barraquer","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.cyto.2020.155256_b0260","doi-asserted-by":"crossref","unstructured":"A. Gordon, L. Gresh, S. Ojeda, L.C. Katzelnick, N. Sanchez, J.C. Mercado, G. Chowell, B. Lopez, D. Elizondo, J. Coloma, R. Burger-Calderon, G. Kuan, A. Balmaseda, E. Harris, Prior dengue virus infection and risk of Zika: a pediatric cohort in Nicaragua, PLoS Med 16(1) (2019) e1002726 10.1371\/journal.pmed.1002726.","DOI":"10.1371\/journal.pmed.1002726"},{"key":"10.1016\/j.cyto.2020.155256_b0265","doi-asserted-by":"crossref","unstructured":"M.K. McCracken, G.D. Gromowski, H.L. Friberg, X. Lin, P. Abbink, R. De La Barrera, K.H. Eckles, L.S. Garver, M. Boyd, D. Jetton, D.H. Barouch, M.C. Wise, B.S. Lewis, J.R. Currier, K. Modjarrad, M. Milazzo, M. Liu, A.B. Mullins, J.R. Putnak, N.L. Michael, R.G. Jarman, S.J. Thomas, Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques, PLoS Pathog 13(8) (2017) e1006487 10.1371\/journal.ppat.1006487.","DOI":"10.1371\/journal.ppat.1006487"},{"key":"10.1016\/j.cyto.2020.155256_b0270","doi-asserted-by":"crossref","unstructured":"C. Serrano-Collazo, E.X. Perez-Guzman, P. Pantoja, M.A. Hassert, I.V. Rodriguez, L. Giavedoni, V. Hodara, L. Parodi, L. Cruz, T. Arana, M.I. Martinez, L. White, J.D. Brien, A. de Silva, A.K. Pinto, C.A. Sariol, Effective control of early Zika virus replication by Dengue immunity is associated to the length of time between the 2 infections but not mediated by antibodies, PLoS Negl Trop Dis 14(5) (2020) e0008285 10.1371\/journal.pntd.0008285.","DOI":"10.1371\/journal.pntd.0008285"},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0275","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00103-019-03060-3","article-title":"Dengue vaccine development: status and future","volume":"63","author":"Wilder-Smith","year":"2020","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.cyto.2020.155256_b0280","doi-asserted-by":"crossref","unstructured":"H. Friberg, L.J. Martinez, L. Lin, J.M. Blaylock, R.A. De La Barrera, A.L. Rothman, J.R. Putnak, K.H. Eckels, S.J. Thomas, R.G. Jarman, J.R. Currier, Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1, mSphere 5(1) (2020) 10.1128\/mSphere.00671-19.","DOI":"10.1128\/mSphere.00671-19"},{"key":"10.1016\/j.cyto.2020.155256_b0285","doi-asserted-by":"crossref","unstructured":"S.R. Hadinegoro, J.L. Arredondo-Garcia, M.R. Capeding, C. Deseda, T. Chotpitayasunondh, R. Dietze, H.I. Muhammad Ismail, H. Reynales, K. Limkittikul, D.M. Rivera-Medina, H.N. Tran, A. Bouckenooghe, D. Chansinghakul, M. Cortes, K. Fanouillere, R. Forrat, C. Frago, S. Gailhardou, N. Jackson, F. Noriega, E. Plennevaux, T.A. Wartel, B. Zambrano, M. Saville, C.-T.D.V.W. Group, Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease, N Engl J Med 373(13) (2015) 1195-206 10.1056\/NEJMoa1506223.","DOI":"10.1056\/NEJMoa1506223"},{"key":"10.1016\/j.cyto.2020.155256_b0290","doi-asserted-by":"crossref","unstructured":"D.Z.L. Mok, K.R. Chan, The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines, Viruses 12(5) (2020) 10.3390\/v12050520.","DOI":"10.3390\/v12050520"},{"issue":"47","key":"10.1016\/j.cyto.2020.155256_b0295","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1016\/j.vaccine.2017.09.089","article-title":"Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age","volume":"35","author":"Halstead","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.cyto.2020.155256_b0300","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2020.155256_b0305","doi-asserted-by":"crossref","unstructured":"V. Ramasamy, U. Arora, R. Shukla, A. Poddar, R.K. Shanmugam, L.J. White, M.M. Mattocks, R. Raut, A. Perween, P. Tyagi, A.M. de Silva, S.K. Bhaumik, M.K. Kaja, F. Villinger, R. Ahmed, R.E. Johnston, S. Swaminathan, N. Khanna, A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice, PLoS Negl Trop Dis 12(1) (2018) e0006191 10.1371\/journal.pntd.0006191.","DOI":"10.1371\/journal.pntd.0006191"},{"key":"10.1016\/j.cyto.2020.155256_b0310","unstructured":"R. Shukla, J.A. Brown, H. Beesetti, R. Ahuja, V. Ramasamy, R.K. Shanmugam, A. Poddar, G. Batra, F. Krammer, J.K. Lim, S. Kale, A. Lal, S. Swaminathan, N. Khanna, Dengue and Zika Virus Infections are enhanced by Live Attenuated Dengue."},{"issue":"3","key":"10.1016\/j.cyto.2020.155256_b0315","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.cyto.2020.155256_b0320","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jfms.2008.09.008","article-title":"A review of feline infectious peritonitis virus infection: 1963\u20132008","volume":"11","author":"Pedersen","year":"2009","journal-title":"J. Feline Med. Surg."},{"issue":"2","key":"10.1016\/j.cyto.2020.155256_b0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tvjl.2014.04.016","article-title":"An update on feline infectious peritonitis: diagnostics and therapeutics","volume":"201","author":"Pedersen","year":"2014","journal-title":"Vet. J."},{"issue":"6","key":"10.1016\/j.cyto.2020.155256_b0330","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jfms.2008.02.006","article-title":"Pathogenesis of feline enteric coronavirus infection","volume":"10","author":"Pedersen","year":"2008","journal-title":"J. Feline Med. Surg."},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0335","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/viro.1998.9045","article-title":"Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses","volume":"243","author":"Vennema","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.cyto.2020.155256_b0340","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1297-9716-45-49","article-title":"Amino acid changes in the spike protein of feline coronavirus correlate with systemic spread of virus from the intestine and not with feline infectious peritonitis","volume":"45","author":"Porter","year":"2014","journal-title":"Vet. Res."},{"issue":"4","key":"10.1016\/j.cyto.2020.155256_b0345","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2460\/ajvr.1995.56.04.429","article-title":"Risk of feline infectious peritonitis in cats naturally infected with feline coronavirus","volume":"56","author":"Addie","year":"1995","journal-title":"Am. J. Vet. Res."},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jfms.2005.04.003","article-title":"Prevalence of feline infectious peritonitis in specific cat breeds","volume":"8","author":"Pesteanu-Somogyi","year":"2006","journal-title":"J. Feline Med. Surg."},{"issue":"Pt 7","key":"10.1016\/j.cyto.2020.155256_b0355","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1099\/vir.0.020214-0","article-title":"Sites of feline coronavirus persistence in healthy cats","volume":"91","author":"Kipar","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.cyto.2020.155256_b0360","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcpa.2018.11.001","article-title":"Inflammatory mediators in the mesenteric lymph nodes, site of a possible intermediate phase in the immune response to feline coronavirus and the pathogenesis of feline infectious peritonitis?","volume":"166","author":"Malbon","year":"2019","journal-title":"J. Comp. Pathol."},{"issue":"6","key":"10.1016\/j.cyto.2020.155256_b0365","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jfms.2006.05.002","article-title":"Whole blood cytokine profiles in cats infected by feline coronavirus and healthy non-FCoV infected specific pathogen-free cats","volume":"8","author":"Gelain","year":"2006","journal-title":"J. Feline Med. Surg."},{"key":"10.1016\/j.cyto.2020.155256_b0370","doi-asserted-by":"crossref","unstructured":"N. Safi, A. Haghani, S.W. Ng, G.T. Selvarajah, F. Mustaffa-Kamal, A.R. Omar, Expression profiles of immune mediators in feline Coronavirus-infected cells and clinical samples of feline Coronavirus-positive cats, BMC Vet Res 13(1) (2017) 92 10.1186\/s12917-017-1019-2.","DOI":"10.1186\/s12917-017-1019-2"},{"issue":"3\u20134","key":"10.1016\/j.cyto.2020.155256_b0375","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0165-2427(03)00156-9","article-title":"Shifts in circulating lymphocyte subsets in cats with feline infectious peritonitis (FIP): pathogenic role and diagnostic relevance","volume":"96","author":"Paltrinieri","year":"2003","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"2\u20134","key":"10.1016\/j.cyto.2020.155256_b0380","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-2427(98)00155-X","article-title":"Some aspects of humoral and cellular immunity in naturally occuring feline infectious peritonitis","volume":"65","author":"Paltrinieri","year":"1998","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"8","key":"10.1016\/j.cyto.2020.155256_b0385","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1128\/JVI.78.8.3863-3871.2004","article-title":"Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis","volume":"78","author":"Haijema","year":"2004","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155256_b0390","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/jvi.64.3.1407-1409.1990","article-title":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization","volume":"64","author":"Vennema","year":"1990","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.cyto.2020.155256_b0395","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0147-9571(81)90003-5","article-title":"Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever","volume":"4","author":"Weiss","year":"1981","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0400","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00201958","article-title":"Immunopathology induced by the feline leukemia virus","volume":"5","author":"Hardy","year":"1982","journal-title":"Springer Semin. Immunopathol."},{"issue":"6","key":"10.1016\/j.cyto.2020.155256_b0405","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1292\/jvms.18-0702","article-title":"Pathogenesis of oral type I feline infectious peritonitis virus (FIPV) infection: antibody-dependent enhancement infection of cats with type I FIPV via the oral route","volume":"81","author":"Takano","year":"2019","journal-title":"J. Vet. Med. Sci."},{"issue":"3\u20134","key":"10.1016\/j.cyto.2020.155256_b0410","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.vetmic.2013.10.015","article-title":"Recombinant feline coronaviruses as vaccine candidates confer protection in SPF but not in conventional cats","volume":"169","author":"Balint","year":"2014","journal-title":"Vet. Microbiol."},{"issue":"2","key":"10.1016\/j.cyto.2020.155256_b0415","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2460\/ajvr.1983.44.02.229","article-title":"Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus","volume":"44","author":"Pedersen","year":"1983","journal-title":"Am. J. Vet. Res."},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0420","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12917-019-1909-6","article-title":"Characterization of antiviral T cell responses during primary and secondary challenge of laboratory cats with feline infectious peritonitis virus (FIPV)","volume":"15","author":"Mustaffa-Kamal","year":"2019","journal-title":"BMC Vet Res"},{"issue":"9","key":"10.1016\/j.cyto.2020.155256_b0425","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2460\/javma.1997.210.09.1313","article-title":"Risk factors for feline infectious peritonitis among cats in multiple-cat environments with endemic feline enteric coronavirus","volume":"210","author":"Foley","year":"1997","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"8","key":"10.1016\/j.cyto.2020.155256_b0430","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/JCM.00636-10","article-title":"Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method","volume":"48","author":"Gaunt","year":"2010","journal-title":"J. Clin. Microbiol."},{"issue":"11","key":"10.1016\/j.cyto.2020.155256_b0435","first-page":"1317","article-title":"Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63","volume":"12","author":"Chan","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2020.155256_b0440","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1155\/2006\/152612","article-title":"An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus","volume":"17","author":"Patrick","year":"2006","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.cyto.2020.155256_b0445","doi-asserted-by":"crossref","unstructured":"S. Khan, R. Nakajima, A. Jain, R.R. de Assis, A. Jasinskas, J.M. Obiero, O. Adenaiye, S. Tai, F. Hong, D.K. Milton, H. Davies, P.L. Felgner, Analysis of serologic cross-reactivity between common human coronaviruses and SARS-CoV-2 using coronavirus antigen microarray, bioRxiv (2020) 2020.03.24.006544 10.1101\/2020.03.24.006544.","DOI":"10.1101\/2020.03.24.006544"},{"key":"10.1016\/j.cyto.2020.155256_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.05.006","article-title":"Host-viral infection maps reveal signatures of severe COVID-19 patients","author":"Bost","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0455","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.virusres.2004.09.004","article-title":"SARS-coronavirus replication in human peripheral monocytes\/macrophages","volume":"107","author":"Yilla","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.cyto.2020.155256_b0460","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-11-82","article-title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus","volume":"11","author":"Yip","year":"2014","journal-title":"Virol J."},{"issue":"5","key":"10.1016\/j.cyto.2020.155256_b0465","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.jtho.2020.03.008","article-title":"Exuberant plasmocytosis in bronchoalveolar lavage specimen of the first patient requiring extracorporeal membrane oxygenation for SARS-CoV-2 in Europe","volume":"15","author":"Giani","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cyto.2020.155256_b0470","unstructured":"M. Woodruff, R. Ramonell, K. Cashman, D. Nguyen, A. Ley, S. Kyu, A. Saini, N. Haddad, W. Chen, J.C. Howell, T. Ozturk, S. Lee, J. Estrada, A. Morrison-Porter, A. Derrico, F. Anam, H. Wu, S. Le, S. Jenks, W. Hu, F.E. Lee, I. Sanz, Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation, medRxiv 10.1101\/2020.04.29.20083717 (2020) 10.1101\/2020.04.29.20083717."},{"key":"10.1016\/j.cyto.2020.155256_b0475","unstructured":"I. Quinti, V. Lougaris, C. Milito, F. Cinetto, A. Pecoraro, I. Mezzaroma, C.M. Mastroianni, O. Turriziani, M.P. Bondioni, M. Filippini, A. Soresina, G. Spadaro, C. Agostini, R. Carsetti, A. Plebani, A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia, J. Allergy Clin. Immunol. 10.1016\/j.jaci.2020.04.013 (2020) 10.1016\/j.jaci.2020.04.013."},{"key":"10.1016\/j.cyto.2020.155256_b0480","doi-asserted-by":"crossref","unstructured":"A. Soresina, D. Moratto, M. Chiarini, C. Paolillo, G. Baresi, E. Foca, M. Bezzi, B. Baronio, M. Giacomelli, R. Badolato, Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover, Pediatr. Allergy Immunol. (2020) 10.1111\/pai.13263.","DOI":"10.1111\/pai.13263"},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0485","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"4","key":"10.1016\/j.cyto.2020.155256_b0490","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.cyto.2020.155256_b0495","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"Luke","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cyto.2020.155256_b0500","doi-asserted-by":"crossref","unstructured":"L. Li, W. Zhang, Y. Hu, X. Tong, S. Zheng, J. Yang, Y. Kong, L. Ren, Q. Wei, H. Mei, C. Hu, C. Tao, R. Yang, J. Wang, Y. Yu, Y. Guo, X. Wu, Z. Xu, L. Zeng, N. Xiong, L. Chen, J. Wang, N. Man, Y. Liu, H. Xu, E. Deng, X. Zhang, C. Li, C. Wang, S. Su, L. Zhang, J. Wang, Y. Wu, Z. Liu, Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial, JAMA 10.1001\/jama.2020.10044 (2020) 10.1001\/jama.2020.10044.","DOI":"10.1001\/jama.2020.10044"},{"key":"#cr-split#-10.1016\/j.cyto.2020.155256_b0505.1","doi-asserted-by":"crossref","unstructured":"X. Tian, C. Li, A. Huang, S. Xia, S. Lu, Z. Shi, L. Lu, S. Jiang, Z. Yang, Y. Wu, T. Ying, Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody, Emerg Microbes Infect 9","DOI":"10.1080\/22221751.2020.1729069"},{"key":"#cr-split#-10.1016\/j.cyto.2020.155256_b0505.2","unstructured":"(1) (2020) 382-385 10.1080\/22221751.2020.1729069."},{"key":"10.1016\/j.cyto.2020.155256_b0510","doi-asserted-by":"crossref","unstructured":"B. Ju, Q. Zhang, J. Ge, R. Wang, J. Sun, X. Ge, J. Yu, S. Shan, B. Zhou, S. Song, X. Tang, J. Yu, J. Lan, J. Yuan, H. Wang, J. Zhao, S. Zhang, Y. Wang, X. Shi, L. Liu, J. Zhao, X. Wang, Z. Zhang, L. Zhang, Human neutralizing antibodies elicited by SARS-CoV-2 infection, Nature 10.1038\/s41586-020-2380-z (2020) 10.1038\/s41586-020-2380-z.","DOI":"10.1101\/2020.03.21.990770"},{"key":"10.1016\/j.cyto.2020.155256_b0515","doi-asserted-by":"crossref","unstructured":"H. Lv, N.C. Wu, O.T. Tsang, M. Yuan, R. Perera, W.S. Leung, R.T.Y. So, J.M.C. Chan, G.K. Yip, T.S.H. Chik, Y. Wang, C.Y.C. Choi, Y. Lin, W.W. Ng, J. Zhao, L.L.M. Poon, J.S.M. Peiris, I.A. Wilson, C.K.P. Mok, Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections, Cell Rep. 31(9) (2020) 107725 10.1016\/j.celrep.2020.107725.","DOI":"10.1016\/j.celrep.2020.107725"},{"issue":"31","key":"10.1016\/j.cyto.2020.155256_b0520","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1016\/j.vaccine.2020.05.064","article-title":"Consensus summary report for CEPI\/BC March 12\u201313, 2020 meeting: assessment of risk of disease enhancement with COVID-19 vaccines","volume":"38","author":"Lambert","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.cyto.2020.155256_b0525","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.vaccine.2006.08.011","article-title":"Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro","volume":"25","author":"Kam","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.cyto.2020.155256_b0530","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.vaccine.2005.06.038","article-title":"Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine","volume":"24","author":"Qin","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.cyto.2020.155256_b0535","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1021\/acsinfecdis.0c00148","article-title":"Correction: immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates","volume":"6","author":"Wang","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.cyto.2020.155256_b0540","doi-asserted-by":"crossref","unstructured":"L. Bao, W. Deng, B. Huang, H. Gao, J. Liu, L. Ren, Q. Wei, P. Yu, Y. Xu, F. Qi, Y. Qu, F. Li, Q. Lv, W. Wang, J. Xue, S. Gong, M. Liu, G. Wang, S. Wang, Z. Song, L. Zhao, P. Liu, L. Zhao, F. Ye, H. Wang, W. Zhou, N. Zhu, W. Zhen, H. Yu, X. Zhang, L. Guo, L. Chen, C. Wang, Y. Wang, X. Wang, Y. Xiao, Q. Sun, H. Liu, F. Zhu, C. Ma, L. Yan, M. Yang, J. Han, W. Xu, W. Tan, X. Peng, Q. Jin, G. Wu, C. Qin, The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice, Nature (2020) 10.1038\/s41586-020-2312-y.","DOI":"10.1101\/2020.02.07.939389"},{"key":"10.1016\/j.cyto.2020.155256_b0545","doi-asserted-by":"crossref","unstructured":"Y.I. Kim, S.G. Kim, S.M. Kim, E.H. Kim, S.J. Park, K.M. Yu, J.H. Chang, E.J. Kim, S. Lee, M.A.B. Casel, J. Um, M.S. Song, H.W. Jeong, V.D. Lai, Y. Kim, B.S. Chin, J.S. Park, K.H. Chung, S.S. Foo, H. Poo, I.P. Mo, O.J. Lee, R.J. Webby, J.U. Jung, Y.K. Choi, Infection and Rapid Transmission of SARS-CoV-2 in Ferrets, Cell Host Microbe 27(5) (2020) 704-709 e2 10.1016\/j.chom.2020.03.023.","DOI":"10.1016\/j.chom.2020.03.023"},{"key":"10.1016\/j.cyto.2020.155256_b0550","doi-asserted-by":"crossref","unstructured":"L. Yuan, Q. Tang, T. Cheng, N. Xia, Animal models for emerging coronavirus: progress and new insights, Emerg Microbes Infect 9(1) (2020) 949-961 10.1080\/22221751.2020.1764871.","DOI":"10.1080\/22221751.2020.1764871"},{"issue":"4","key":"10.1016\/j.cyto.2020.155256_b0555","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41591-020-0817-4","article-title":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding","volume":"26","author":"Xu","year":"2020","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cyto.2020.155256_b0560","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.cyto.2020.155256_b0565","doi-asserted-by":"crossref","unstructured":"J. Hadjadj, N. Yatim, L. Barnabei, A. Corneau, J. Boussier, H. Pere, B. Charbit, V. Bondet, C. Chenevier-Gobeaux, P. Breillat, N. Carlier, R. Gauzit, C. Morbieu, F. Pene, N. Marin, N. Roche, T.-A. Szwebel, N. Smith, S. Merkling, J.-M. Treluyer, D. Veyer, L. Mouthon, C. Blanc, P.-L. Tharaux, F. Rozenberg, A. Fischer, D. Duffy, F. Rieux-Laucat, S. Kerneis, B. Terrier, Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients, medRxiv (2020) 10.1101\/2020.04.19.20068015.","DOI":"10.1101\/2020.04.19.20068015"},{"issue":"4","key":"10.1016\/j.cyto.2020.155256_b0570","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med."},{"issue":"5","key":"10.1016\/j.cyto.2020.155256_b0575","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","article-title":"Pulmonary pathology of early-phase 2019 Novel Coronavirus (COVID-19) pneumonia in two patients with lung cancer","volume":"15","author":"Tian","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.cyto.2020.155256_b0580","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/jclinpath-2020-206522","article-title":"Autopsy in suspected COVID-19 cases","volume":"73","author":"Hanley","year":"2020","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cyto.2020.155256_b0585","doi-asserted-by":"crossref","unstructured":"P. Mehta, D.F. McAuley, M. Brown, E. Sanchez, R.S. Tattersall, J.J. Manson, U.K. Hlh Across Speciality Collaboration, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet 395(10229) (2020) 1033-1034 10.1016\/S0140-6736(20)30628-0.","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"10.1016\/j.cyto.2020.155256_b0590","doi-asserted-by":"crossref","unstructured":"D. Blanco-Melo, B.E. Nilsson-Payant, W.C. Liu, S. Uhl, D. Hoagland, R. Moller, T.X. Jordan, K. Oishi, M. Panis, D. Sachs, T.T. Wang, R.E. Schwartz, J.K. Lim, R.A. Albrecht, B.R. tenOever, Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19, Cell 181(5) (2020) 1036-1045 e9 10.1016\/j.cell.2020.04.026.","DOI":"10.1016\/j.cell.2020.04.026"},{"issue":"2","key":"10.1016\/j.cyto.2020.155256_b0595","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated Type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cyto.2020.155256_b0600","unstructured":"Z. Zhou, L. Ren, L. Zhang, J. Zhong, Y. Xiao, Z. Jia, L. Guo, J. Yang, C. Wang, S. Jiang, D. Yang, G. Zhang, H. Li, F. Chen, Y. Xu, M. Chen, Z. Gao, J. Yang, J. Dong, B. Liu, X. Zhang, W. Wang, K. He, Q. Jin, M. Li, J. Wang, Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients, Cell Host Microbe 10.1016\/j.chom.2020.04.017 (2020) 10.1016\/j.chom.2020.04.017."},{"issue":"9","key":"10.1016\/j.cyto.2020.155256_b0605","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1172\/JCI126363","article-title":"IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes","volume":"129","author":"Channappanavar","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2020.155256_b0610","doi-asserted-by":"crossref","unstructured":"I.C. Huang, C.C. Bailey, J.L. Weyer, S.R. Radoshitzky, M.M. Becker, J.J. Chiang, A.L. Brass, A.A. Ahmed, X. Chi, L. Dong, L.E. Longobardi, D. Boltz, J.H. Kuhn, S.J. Elledge, S. Bavari, M.R. Denison, H. Choe, M. Farzan, Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus, PLoS Pathog 7(1) (2011) e1001258 10.1371\/journal.ppat.1001258.","DOI":"10.1371\/journal.ppat.1001258"},{"issue":"9","key":"10.1016\/j.cyto.2020.155256_b0615","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.3390\/v6093683","article-title":"IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms","volume":"6","author":"Wrensch","year":"2014","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.cyto.2020.155256_b0620","doi-asserted-by":"crossref","first-page":"e02143","DOI":"10.1128\/JVI.02143-16","article-title":"The severe acute respiratory syndrome coronavirus nucleocapsid inhibits Type I interferon production by interfering with TRIM25-mediated RIG-I Ubiquitination","volume":"91","author":"Hu","year":"2017","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.cyto.2020.155256_b0625","doi-asserted-by":"crossref","first-page":"e8342","DOI":"10.1371\/journal.pone.0008342","article-title":"The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor","volume":"4","author":"Minakshi","year":"2009","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.cyto.2020.155256_b0630","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1440-1843.2006.00942.x","article-title":"Temporal changes in cytokine\/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome","volume":"11","author":"Chien","year":"2006","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.cyto.2020.155256_b0635","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2020.155256_b0640","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1128\/IAI.72.8.4410-4415.2004","article-title":"Analysis of serum cytokines in patients with severe acute respiratory syndrome","volume":"72","author":"Zhang","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2020.155256_b0645","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1465-9921-6-42","article-title":"Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS","volume":"6","author":"Wang","year":"2005","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.cyto.2020.155256_b0650","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1165\/rcmb.2012-0339OC","article-title":"Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus","volume":"48","author":"Qian","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.cyto.2020.155256_b0655","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"10223","key":"10.1016\/j.cyto.2020.155256_b0660","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2020.155256_b0665","doi-asserted-by":"crossref","unstructured":"D.M. Del Valle, S. Kim-schulze, H. Hsin-hui, N.D. Beckmann, S. Nirenberg, B. Wang, Y. Lavin, T. Swartz, D. Madduri, A. Stock, T. Marron, H. Xie, M.K. Patel, O. van Oekelen, A. Rahman, P. Kovatch, J. Aberg, E. Schadt, S. Jagannath, M. Mazumdar, A. Charney, A. Firpo-Betancourt, D.R. Mendu, J. Jhang, D. Reich, K. Sigel, C. Cordon-Cardo, M. Feldmann, S. Parekh, M. Merad, S. Gnjatic, An inflammatory cytokine signature helps predict COVID-19 severity and death, medRxiv (2020) 10.1101\/2020.05.28.20115758.","DOI":"10.1101\/2020.05.28.20115758"},{"key":"10.1016\/j.cyto.2020.155256_b0670","doi-asserted-by":"crossref","unstructured":"J. Wang, M. Jiang, X. Chen, L.J. Montaner, Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts, J Leukoc Biol 10.1002\/JLB.3COVR0520-272R (2020) 10.1002\/JLB.3COVR0520-272R.","DOI":"10.1002\/JLB.3COVR0520-272R"},{"issue":"6","key":"10.1016\/j.cyto.2020.155256_b0675","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41591-018-0041-7","article-title":"CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade","volume":"24","author":"Giavridis","year":"2018","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cyto.2020.155256_b0680","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cyto.2020.155256_b0685","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","article-title":"Cytokine storm and sepsis disease pathogenesis","volume":"39","author":"Chousterman","year":"2017","journal-title":"Semin Immunopathol"},{"issue":"7","key":"10.1016\/j.cyto.2020.155256_b0690","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2020.155256_b0695","doi-asserted-by":"crossref","unstructured":"A.J. Wilk, A. Rustagi, N.Q. Zhao, J. Roque, G.J. Martinez-Colon, J.L. McKechnie, G.T. Ivison, T. Ranganath, R. Vergara, T. Hollis, L.J. Simpson, P. Grant, A. Subramanian, A.J. Rogers, C.A. Blish, A single-cell atlas of the peripheral immune response in patients with severe COVID-19, Nat. Med. (2020) 10.1038\/s41591-020-0944-y.","DOI":"10.1101\/2020.04.17.20069930"},{"key":"10.1016\/j.cyto.2020.155256_b0700","doi-asserted-by":"crossref","unstructured":"M. Liao, Y. Liu, J. Yuan, Y. Wen, G. Xu, J. Zhao, L. Cheng, J. Li, X. Wang, F. Wang, L. Liu, I. Amit, S. Zhang, Z. Zhang, Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19, Nat. Med. (2020) 10.1038\/s41591-020-0901-9.","DOI":"10.1038\/s41591-020-0901-9"},{"issue":"7","key":"10.1016\/j.cyto.2020.155256_b0705","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2004-10-4166","article-title":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells","volume":"106","author":"Law","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cyto.2020.155256_b0710","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.3201\/eid1111.040659","article-title":"Neutralizing antibody response and SARS severity","volume":"11","author":"Ho","year":"2005","journal-title":"Emerg. Infect. Dis."},{"issue":"6","key":"10.1016\/j.cyto.2020.155256_b0715","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3201\/eid2206.160010","article-title":"Antibody response and disease severity in healthcare worker MERS survivors","volume":"22","author":"Alshukairi","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cyto.2020.155256_b0720","doi-asserted-by":"crossref","unstructured":"K.V. Houser, A.J. Broadbent, L. Gretebeck, L. Vogel, E.W. Lamirande, T. Sutton, K.W. Bock, M. Minai, M. Orandle, I.N. Moore, K. Subbarao, Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody, PLoS Pathog 13(8) (2017) e1006565 10.1371\/journal.ppat.1006565.","DOI":"10.1371\/journal.ppat.1006565"},{"key":"10.1016\/j.cyto.2020.155256_b0725","doi-asserted-by":"crossref","unstructured":"C.T. Tseng, E. Sbrana, N. Iwata-Yoshikawa, P.C. Newman, T. Garron, R.L. Atmar, C.J. Peters, R.B. Couch, Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus, PLoS One 7(4) (2012) e35421 10.1371\/journal.pone.0035421.","DOI":"10.1371\/journal.pone.0035421"},{"key":"10.1016\/j.cyto.2020.155256_b0730","doi-asserted-by":"crossref","unstructured":"L. Liu, Q. Wei, Q. Lin, J. Fang, H. Wang, H. Kwok, H. Tang, K. Nishiura, J. Peng, Z. Tan, T. Wu, K.W. Cheung, K.H. Chan, X. Alvarez, C. Qin, A. Lackner, S. Perlman, K.Y. Yuen, Z. Chen, Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection, JCI Insight 4(4) (2019) e123158 10.1172\/jci.insight.123158.","DOI":"10.1172\/jci.insight.123158"},{"key":"10.1016\/j.cyto.2020.155256_b0735","doi-asserted-by":"crossref","unstructured":"K. Garber, Coronavirus vaccine developers wary of errant antibodies, Nat. Biotechnol. 10.1038\/d41587-020-00016-w (2020) 10.1038\/d41587-020-00016-w.","DOI":"10.1038\/d41587-020-00016-w"},{"issue":"5","key":"10.1016\/j.cyto.2020.155256_b0740","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.chom.2020.04.021","article-title":"The challenges of vaccine development against a new virus during a pandemic","volume":"27","author":"Diamond","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.cyto.2020.155256_b0745","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41577-020-0323-4","article-title":"COVID-19 vaccine design: the Janus face of immune enhancement","volume":"20","author":"Hotez","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2020.155256_b0750","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-0402-6","article-title":"T cell responses in patients with COVID-19","author":"Chen","year":"2020","journal-title":"Nat. Rev. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620302726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620302726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:58:41Z","timestamp":1760907521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620302726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":152,"alternative-id":["S1043466620302726"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155256","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155256"}}